Exact Sciences Corp (EXAS)

115.87 -1.39  -1.19% NASDAQ Nov 25, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/11/2021 Earnings Exact Sciences Corp Fourth Quarter Earnings for 2020 Release
02/11/2021 17:00 EST Misc Exact Sciences Corp Fourth Quarter Earnings Conference Call for 2020
10/29/2020 17:00 EDT Misc Exact Sciences Corp Third Quarter Earnings Conference Call for 2020
10/29/2020 Earnings Exact Sciences Corp Third Quarter Earnings Result for 2020
07/30/2020 17:00 EDT Misc Exact Sciences Corp Second Quarter Earnings Conference Call for 2020
07/30/2020 Earnings Exact Sciences Corp Second Quarter Earnings Result for 2020
07/23/2020 11:00 EDT Misc Exact Sciences Corp Annual General Meeting for 2019
05/06/2020 17:00 EDT Misc Exact Sciences Corp First Quarter Earnings Conference Call for 2020
05/06/2020 Earnings Exact Sciences Corp First Quarter Earnings Result for 2020
02/21/2020 Misc Exact Sciences Corp Annual Report for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.exactsciences.com
  • Investor Relations URL: http://investor.exactsciences.com/investor-relations/default.aspx
  • HQ State/Province: Wisconsin
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Feb. 11, 2021
  • Last Earnings Release: Oct. 29, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of certain types of cancer. Its core product is a noninvasive screening test, Cologuard, which analyzes stool-based DNA samples to detect the precancerous and early stages of colorectal cancer. The test includes DNA markers and a protein marker that can detect blood in the stool. Exact Sciences receives revenue from two sources: laboratory services and licensing fees. Its laboratory services revenue is generated by diagnostic services that use the Cologuard test. Exact Sciences also receives revenue from the licensing of its product rights.

Top Fund Holders

Symbol Name Weighting
BBH VanEck Vectors Biotech ETF 4.86%
DFRIX Delaware Smid Cap Growth R 4.83%
FBT First Trust NYSE Arca Biotech ETF 3.84%
ARKG ARK Genomic Revolution ETF 3.41%
GOFFX Invesco Global Opp R5 3.39%
ETCGX Eventide Gilead C 2.88%
ZUH.TO BMO Eq Wght US HlthCare Hdgd to CAD ETF 2.27%
HGOTX Hartford Growth Opportunities R5 2.04%
TRUZX T. Rowe Price New Horizons Z 2.00%
APDMX Artisan Mid Cap Advisor 1.95%
FXH First Trust Health Care AlphaDEX® ETF 1.75%
XBI SPDR® S&P Biotech ETF 1.31%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.